EGFR family members contribute to cancer cell survival through multiple mechanisms including changes in signaling pathways, decreased degradation of the receptor through changes in the endocytosis pathway, and epigenetic changes that lead to changes in transcription (Figure 1). This evidence concerns the gene EGFR and cancer.